4ckr: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='4ckr' size='340' side='right'caption='[[4ckr]], [[Resolution|resolution]] 2.20Å' scene=''> | <StructureSection load='4ckr' size='340' side='right'caption='[[4ckr]], [[Resolution|resolution]] 2.20Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4ckr]] is a 1 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4ckr]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=4bki 4bki]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CKR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CKR FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DI1:4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-N-{4-METHYL-3-[(2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL)OXY]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE'>DI1</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DI1:4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-N-{4-METHYL-3-[(2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL)OXY]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE'>DI1</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ckr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ckr OCA], [https://pdbe.org/4ckr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ckr RCSB], [https://www.ebi.ac.uk/pdbsum/4ckr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ckr ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | |||
[[https://www.uniprot.org/uniprot/DDR1_HUMAN DDR1_HUMAN]] | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 24: | Line 25: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Arrowsmith CH]] | |||
[[Category: Arrowsmith | [[Category: Bountra C]] | ||
[[Category: Bountra | [[Category: Bullock A]] | ||
[[Category: Bullock | [[Category: Canning P]] | ||
[[Category: Canning | [[Category: Chaikuad A]] | ||
[[Category: Chaikuad | [[Category: Dixon-Clarke S]] | ||
[[Category: Edwards AM]] | |||
[[Category: Dixon-Clarke | [[Category: Elkins JM]] | ||
[[Category: Edwards | [[Category: Goubin S]] | ||
[[Category: Elkins | [[Category: Krojer T]] | ||
[[Category: Goubin | [[Category: Mahajan P]] | ||
[[Category: Krojer | [[Category: Newman JA]] | ||
[[Category: Mahajan | [[Category: Von Delft F]] | ||
[[Category: Newman | |||
[[Category: | |||
Revision as of 10:19, 14 September 2022
Crystal structure of the human DDR1 kinase domain in complex with DDR1-IN-1Crystal structure of the human DDR1 kinase domain in complex with DDR1-IN-1
Structural highlights
FunctionPublication Abstract from PubMedThe DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 A DDR1 co-crystal structure. DDR1-IN-1 binds to DDR1 in the 'DFG-out' conformation and inhibits DDR1 autophosphorylation in cells at submicromolar concentrations with good selectivity as assessed against a panel of 451 kinases measured using the KinomeScan technology. We identified a mutation in the hinge region of DDR1, G707A, that confers >20-fold resistance to the ability of DDR1-IN-1 to inhibit DDR1 autophosphorylation and can be used to establish what pharmacology is DDR1-dependent. A combinatorial screen of DDR1-IN-1 with a library of annotated kinase inhibitors revealed that inhibitors of PI3K and mTOR such as GSK2126458 potentiate the antiproliferative activity of DDR1-IN-1 in colorectal cancer cell lines. DDR1-IN-1 provides a useful pharmacological probe for DDR1-dependent signal transduction. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.,Kim HG, Tan L, Weisberg EL, Liu F, Canning P, Choi HG, Ezell SA, Wu H, Zhao Z, Wang J, Mandinova A, Griffin JD, Bullock AN, Liu Q, Lee SW, Gray NS ACS Chem Biol. 2013 Oct 18;8(10):2145-50. doi: 10.1021/cb400430t. Epub 2013 Aug, 13. PMID:23899692[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||